GansoManso Posted - 21 hours ago

$CTSO Are we going up now? If so, I hope everyone bought the dip. Thank you, MM.

Medical12 Posted - 22 hours ago

$CTSO this uplift could be the first indicator I assume data are good to go

Medical12 Posted - 1 day ago

$CTSO guess we will see a huge jump after the presentation. Data must be good for this indication otherwise it wouldn’t be presented, just my opinion

Stock_Titan Posted - 2 days ago

$CTSO STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting https://www.stocktitan.net/news/CTSO/star-t-pivotal-trial-results-to-be-featured-as-a-late-breaking-tosablux5xq2.html

GansoManso Posted - 4 days ago

$CTSO almost ready... bring it down a bit more please

jacksonjohn750 Posted - 1 week ago

$CTSO dead

jacksonjohn750 Posted - 1 week ago

$CTSO nice recovery, was too chicken to buy at the lows

sg44 Posted - 2 weeks ago

$CYTH Let's see which stock is higher in one year. $cyth or $CTSO

Jdizzy4 Posted - 03/25/24

$CTSO it appears $ICU built a better mousetrap.

Medical12 Posted - 03/22/24

$CTSO rebound soon

NJ125 Posted - 03/22/24

$CTSO Any stock offering would seem to be potentially dilutive and knock the stock down to $0.80???

Medical12 Posted - 4 weeks ago

$CTSO

Fullratio Posted - 1 month ago

$CTSO quick ratio has shrunk by 51% YoY but it is up by 10% QoQ: https://fullratio.com/stocks/nasdaq-ctso/cytosorbents

jacksonjohn750 Posted - 1 month ago

$CTSO

Medical12 Posted - 1 month ago

$CTSO for me Cyto is still a startup and maybe the numbers doesn’t look that good at this point of time. Which is / was not 100%manageable by the board. They still have a product(s) which could be game changer for critical sick patients and I am strongly believe this will payback as soon as we open up the U.S. market. This filter could be used for much more indications which means the addressable market is huge and it is increasing YoY as we all getting older. If the FDA clearance is done….investors or even buyout is coming. We shouldn’t focus to 100% on the numbers, we need consider the huge potential and to be honest we are trading the future. Knowing with startup’s there is always a risk but also huge chances. Just my personal opinion

BioGem Posted - 1 month ago

$CTSO Their product is not in demand, as confirmed by shrinking revenues and the deepest operating loss in more than 3 years. What concerns me most is their near-term financial situation. With 54.3M Sh o/s, the market cap is still too high: many critical negatives: -Cash burn in Q1, as they pay bonuses, public Co. expenses, auditors, etc. will be around -5M. Thus, non-restricted cash in March 2024 is near 9M. -Add a short-term debt due soon to the cash burn in Q2 2024, and you can see how cash can be in the 4-5M range by June. -A large equity offering (relative to market cap) is needed by summertime; probably at a stock price below $0.9 = substantial number of shares to be issued.

Medical12 Posted - 1 month ago

$CTSO are invested?

jacksonjohn750 Posted - 1 month ago

$CTSO This will not move until they can show solvency. They can't take this through FDA until they get more funding. It won't last until FDA approval... IF... and the labeling maybe restrictive with the trial result they had

Kenzo71 Posted - 1 month ago

$CTSO some posters probably think that if the data released at the Cardiothoracic surgery conference at the end of April is good, the share price will begin to recover. It MIGHT rise to $1.00, but the negative factors far outweigh the positives. An investment in CTSO is dead money until they get an FDA approval AND they can execute an effective commercialization strategy. Both won’t be known until 2025!

Medical12 Posted - 1 month ago

$CTSO agree the Q4 was bad, full year FY23 was ok at least from the revenue and margin point of view. They have cash to cover 2024, even if 15% left the company this is a normal situation these day. Cyto is still a start up company, but again if FDA clearance is coming we are improving a lot. The risk is still there, but when do you normally buy shares? When the price is down, right? So now it would be the best time. At least in my opinion knowing the potential risk.

hanovk68 Posted - 1 month ago

$CTSO Noticed how none of the analysts on the call said “congratulations on a great quarter.” That’s because is was a lousy quarter! So, 15% of the employees have been let go, and the executive team hasn’t had a pay increase in three years. The Company’s cash balances are hemoraging and no FDA decision on DrugSorb-ATR is likely before 2025. ABSOLUTELY NO REASON TO INVEST YOUR HARD EARNED MONEY IN THIS COMPANY AT THE PRESENT TIME IMHO.

Medical12 Posted - 1 month ago

$CTSO I was on the same call, but I saw a much better picture. I am still optimistic. Revenue grew by 5% not to bad with all the market challenges. Margin 72%. They have products in the pipeline. India is coming in scope as well. Other markets are catching up. Cash flow is for 2024 more less ok. Key is FDA and then we are easily back to $ 5-10

hanovk68 Posted - 1 month ago

$CTSO 2023 Annual and 4Q revenues were below those reported for the American period in 2022. They would’ve been even worse if there had not been a positive currency revaluation. DrugSorb ATR FDA submission has been pushed back to 2nd half of 2024 suggesting that an FDA decision probably won’t come until 1st half of 2025. Current available cash is around $16 million, cash burn is $4million/quarter and expected to decline to $3million/quarter beginning in 2nd half of 2024. Conserving capital is a major corporate priority. Executive pay freezes have been in effect since 2022, 15% of the workforce has been laid-off and all options are being explored to raise additional capital to maintain operations. IMHO, the share price likely will go down further. We shall see!

Rain00007 Posted - 1 month ago

$CTSO this will go to zero

epsguid Posted - 1 month ago

$CTSO reported a loss of $0.12, consensus was ($0.14) via @eWhispers #epsbeat http://eps.sh/d/ctso

Stock_Titan Posted - 1 month ago

$CTSO CytoSorbents Reports Fourth Quarter and Full Year 2023 Results https://www.stocktitan.net/news/CTSO/cyto-sorbents-reports-fourth-quarter-and-full-year-2023-v4dqygn6dkmm.html

Medical12 Posted - 1 month ago

$CTSO hopefully the number are more less stabil or better positive at least the revenue for now. The game changer will be the FDA clearances. Then we are moving back $ xx

jacksonjohn750 Posted - 1 month ago

$CTSO Dead?

Stock_Titan Posted - 1 month ago

$CTSO CytoSorbents to Report Fiscal 2023 Operating and Financial Results https://www.stocktitan.net/news/CTSO/cyto-sorbents-to-report-fiscal-2023-operating-and-financial-9oaxj2fopp5m.html

NJ125 Posted - 1 month ago

$CTSO will there be some good news presented by Chan at March 6 Cowen Conference??